Explore another way you may receive treatment.

Potential OPDIVO® (nivolumab) user laughing in the kitchen with her husband.
Potential OPDIVO® (nivolumab) user laughing in the kitchen with her husband.

Your fight against
head and neck cancer
may continue here

OPDIVO is an FDA-approved immunotherapy option to treat head and neck squamous cell carcinoma that has returned or spread after previous treatment

Actor portrayals.

Previously treated squamous cell cancer of the head and neck

OPDIVO is a treatment option for certain adults with squamous cell carcinoma of the head and neck (SCCHN) that has returned or spread after previous treatment

See treatment plans and what to expect from an OPDIVO® IV infusion or OPDIVO® QVANTIG™ subcutaneous injection.
Explore another way you may receive treatment

You and your healthcare provider may have a choice between under-the-skin injections (subcutaneous injection) with OPDIVO Qvantig and intravenous (lV) infusions with OPDIVO

OPDIVO Qvantig cannot be used in combination with YERVOY. OPDIVO and OPDIVO Qvantig will not work for everyone. Individual results may vary.

Man exploring real patients stories of experiences with OPDIVO® (nivolumab) or other OPDIVO-based combinations.

Patient stories

Real patients share their experiences with OPDIVO and OPDIVO-based treatments

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about getting treatment, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO



466-US-2500011  03/25